It examines FDAs efforts prepare inspection reports & take enforcement actions against foreign pharmaceutical manufacturers in a timely manner; improve the consistency with which FDA evaluates the results of foreign inspections & conducts reinspections to verify that foreign pharmaceutical manufacturers have corrected serious deficiencies; conduct routine inspections of foreign pharmaceutical manufacturers to monitor their compliance with U.S. quality standards; & improve the management of data needed for planning inspection, monitoring inspection results, & taking enforcement actions. Charts & tables.